Governance C21 Investments Inc.

CXXI

CA12675Q1019

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 09:38:34 2024-09-18 am EDT			5-day change	1st Jan Change
0.3150 ^CAD	0.00%		-10.00%	-1.56%

Aug. 16	C21 Investments Reports Q1 Net Loss, no Comparable Figures Available	MT
Aug. 16	C21 Investments Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI

Executive Committee: C21 Investments Inc.

Manager

Positions heldSince

Sonny Newman

Chief Executive Officer	2019-07-07
President	2019-07-07

Michael Kidd

Director of Finance/CFO	2018-07-25
Investor Relations Contact	2018-07-25
Corporate Secretary	2018-07-25

Aron Swan

Chief Operating Officer

2023-09-06

Composition of the Board of Directors: C21 Investments Inc.

Director

CommitteesSince

Donald Macdonald

Audit Committee Chair	2020-08-17
Compensation Committee Chair	2020-08-17
Governance Committee Chair	2020-08-17

Leonard Werden

Audit Committee	2017-07-24
Compensation Committee	2017-07-24
Governance Committee	2017-07-24

Todd Harrison

Compensation Committee	2021-02-14
Governance Committee	2021-02-14

Michael Kidd

Director/Board Member

2018-10-02

Latest Appointments: C21 Investments Inc.

C21 Investments Inc. Announces Appointment of Aron Swan as Chief Operating Officer	23-09-07	CI
C21 Investments Inc. Announces Board Changes	21-01-29	CI
C21 Investments Inc. Names Bruce Macdonald to the Role of Non-Executive Chairman of the Board	20-08-18	CI
C21 Investments Inc. Announces Retirement of Keturah Nathe from the Board of Directors	19-10-10	CI
C21 Investments Inc. Announces Management Changes	19-07-09	CI
C21 Investments Inc. Announces Retirement of Christopher Cherry from Board	19-01-25	CI
C21 Investments Inc. Announces Executive Changes	18-12-27	CI

More news

Former Officers and Directors: C21 Investments Inc.

Insider

Positions held

SinceUntil

Skyler Pinnick

Director/Board Member	2018-10-02	2021-11-30
Public Communications Contact	2018-10-02	2021-11-30
Sales & Marketing	2018-10-02	2021-11-30

Russell Rotondi

General Counsel

2021-07-04

John Robert Cheney

Director/Board Member	2017-08-02	2021-01-27
Chief Executive Officer	2017-10-12	2019-07-07
President	2017-10-12	2019-07-07

Andrew Marchington

Comptroller/Controller/Auditor

2019-10-31

Keturah Nathe

Director/Board Member	2018-01-24	2019-10-09
Corporate Officer/Principal	2018-01-24	2019-10-09

Randy Torcom

Corporate Officer/Principal

2018-07-30

2019-07-31

John Dempsey

Corporate Officer/Principal

2018-09-20

2019-06-30

Christopher Cherry

Director/Board Member	2015-06-16	2019-01-23
Director of Finance/CFO	2015-06-16	2018-07-25
Corporate Secretary	2015-06-16	2018-07-25

Trevor Wilson

Director/Board Member	2017-10-12	2018-01-24
Independent Dir/Board Member	2017-10-12	2018-01-24

Jurgen Wolf

Director/Board Member	2012-10-24	2017-10-15
Chief Executive Officer	2012-10-24	2017-10-15
President	2012-10-24	2017-10-15

Harold J. Noyes

Director/Board Member	2012-03-20	2017-08-02
Independent Dir/Board Member	2012-03-20	2017-08-02

Huitt Tracey

Director/Board Member	2012-07-09	2015-06-17
Independent Dir/Board Member	2012-07-09	2015-06-17

Michael Pound

Director/Board Member

2013-07-16

Robert K. Kramer

Director/Board Member	2013-07-16	2013-07-16
Director of Finance/CFO	2013-07-16	2013-07-16
Independent Dir/Board Member	2013-07-16	2013-07-16
Corporate Secretary	2013-07-16	2013-07-16

Robert B. Pincombe

Director/Board Member	1987-01-14	2012-10-24
President	1987-01-14	2012-10-24

David D. McKee

Director/Board Member	2009-09-30	2012-07-09
Director of Finance/CFO	2009-09-30	2009-09-30
Investor Relations Contact	2004-03-14	2012-07-09
Public Communications Contact	2009-09-30	2012-07-09

Eric N. Ascroft

Director/Board Member	2009-09-30	2012-03-20
Independent Dir/Board Member	1998-07-16	2012-03-20

Robert A. Davies

Director-Back Office Operation	2009-09-30	2009-09-30
Director/Board Member	2009-09-30	2012-03-20
Independent Dir/Board Member	2008-05-26	2012-03-20

Michael Berisoff

Corporate Officer/Principal

Jim Stapleton

Chief Operating Officer

2010-09-07

Age distribution of managers

Parity Men Women

Male	6
Female	0

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	4
Female	0

ESG Refinitiv

C21 Investments Inc. is a Canada-based vertically integrated cannabis company. The Company cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry- retail revenues with multi-market branded consumer packaged goods. The Company holds licenses in Nevada spanning the entire cannabis supply chain. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. The Company operates in the state of Nevada.

Employees

116

Sector

Pharmaceuticals

Calendar

2024-09-24 - Q2 2025 Earnings Release (Projected)

More about the company